Your browser doesn't support javascript.
loading
Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study.
Saeki, H; Kabashima, K; Tokura, Y; Murata, Y; Shiraishi, A; Tamamura, R; Randazzo, B; Imanaka, K.
Afiliação
  • Saeki H; Department of Dermatology, Nippon Medical School, Tokyo, Japan.
  • Kabashima K; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Tokura Y; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Murata Y; Janssen Pharmaceutical K.K., Tokyo, Japan.
  • Shiraishi A; Janssen Pharmaceutical K.K., Tokyo, Japan.
  • Tamamura R; Janssen Pharmaceutical K.K., Tokyo, Japan.
  • Randazzo B; Immunology, Janssen Research & Development, LLC, Spring House, PA, U.S.A.
  • Imanaka K; Janssen Pharmaceutical K.K., Tokyo, Japan.
Br J Dermatol ; 177(2): 419-427, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28338223
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Fármacos Dermatológicos / Ustekinumab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Fármacos Dermatológicos / Ustekinumab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article